GWAYF.US Greenway Greenhouse Cannabis Corporation

Healthcare Pharmaceuticals USA Stocks
0.0579 USD
Close of Nov 14, 2026
0.0517 0.2705
Market cap
USD 7.72M
P/E
-
P/B
1.54x
ROE
-37.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is GWAYF.US undervalued?

Graham number

The Graham number of Greenway Greenhouse Cannabis Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Greenway Greenhouse Cannabis Corporation fundamental analysis

No fundamental analysis for Greenway Greenhouse Cannabis Corporation yet.

Greenway Greenhouse Cannabis Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Greenway Greenhouse Cannabis Corporation

Greenway Greenhouse Cannabis Corporation engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis. The company was incorporated in 2018 and is based in Kingsville, Canada. Greenway Greenhouse Cannabis Corporation is a subsidiary of Sunrite Greenhouses Ltd.

Full company profile